Your browser doesn't support javascript.
loading
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.
Day, John W; Mendell, Jerry R; Mercuri, Eugenio; Finkel, Richard S; Strauss, Kevin A; Kleyn, Aaron; Tauscher-Wisniewski, Sitra; Tukov, Francis Fonyuy; Reyna, Sandra P; Chand, Deepa H.
Affiliation
  • Day JW; Department of Neurology, Stanford University Medical Center, MC 5979, 213 Quarry Road, Palo Alto, CA, 94304, USA. jwday@stanford.edu.
  • Mendell JR; Center for Gene Therapy, Nationwide Children's Hospital, Columbus, OH, USA.
  • Mercuri E; Department of Pediatrics, Ohio State University, Columbus, OH, USA.
  • Finkel RS; Department of Neurology, Ohio State University, Columbus, OH, USA.
  • Strauss KA; Department of Paediatric Neurology and Nemo Clinical Centre, Catholic University, Rome, Italy.
  • Kleyn A; Centro Clinico Nemo, Fondazione Policlinico Gemelli IRCCS, Rome, Italy.
  • Tauscher-Wisniewski S; Department of Pediatrics, Nemours Children's Hospital, Orlando, FL, USA.
  • Tukov FF; Center for Experimental Neurotherapeutics, St. Jude's Children's Research Hospital, Memphis, TN, USA.
  • Reyna SP; Clinic for Special Children, Strasburg, PA, USA.
  • Chand DH; Penn Medicine-Lancaster General Hospital, Lancaster, PA, USA.
Drug Saf ; 44(10): 1109-1119, 2021 10.
Article in En | MEDLINE | ID: mdl-34383289
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Muscular Atrophy, Spinal / Genetic Therapy Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Muscular Atrophy, Spinal / Genetic Therapy Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: New Zealand